Assessing 72-Hour Efficacy of Tripled Daily Buprenorphine Maintenance Dose
Data Collection
Narcotic-Related Disorders+2
+ Mental Disorders
+ Opioid-Related Disorders
Treatment Study
Summary
Study start date: June 1, 1993
Actual date on which the first participant was enrolled.This study aims to explore the effects of alternate-day administration of Buprenorphine, a medication used for opioid dependence. The goal is to understand if a dose three times the daily maintenance amount can last for 72 hours without any changes in its effects. The study focuses on individuals who require opioid dependence treatment, seeking to address the challenge of maintaining consistent effects with less frequent dosing. The potential outcomes of this research could lead to improved treatment strategies for opioid dependence, making treatment more manageable for those affected.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 20 to 49 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Please contact site for information.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location